Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial

Author:

Han Baohui1ORCID,Jin Bo1,Chu Tianqing1,Niu Yanjie1,Dong Yu1,Xu Jianlin1,Gu Aiqing1,Zhong Hua1,Wang Huimin1,Zhang Xueyan1,Shi Chunlei1,Zhang Yanwei1,Zhang Wei1,Lou Yuqing1,Zhu Lei2,Pei Jun1

Affiliation:

1. Department of Pulmonary; Shanghai Chest Hospital, Shanghai Jiaotong University; Shanghai China

2. Department of Pathology; Shanghai Chest Hospital, Shanghai Jiaotong University; Shanghai China

Funder

Key Projects of the Biomedicine Department, Science and Technology Commission of Shanghai Municipality

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference37 articles.

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3